Media News

Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan

SHANGHAI, March 28, 2022 /PRNewswire/ -- Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently announced that it has received registration approval from Japan Pharmaceuticals and Medical Devices Agency (PMDA) for its independently-developed Hyperflex® Balloon Catheter (Hyperflex®) as the company's first product approved for marketing in Japan. Hyperflex® obtained CE Mark in 2016 and is already available in overseas...

InnoCare Announces Approval of Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China

BEIJING, March 28, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) announced today that the company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration) for its TYK2 JH2 allosteric inhibitor ICP-488, which is the Company's third innovative drug for the treatment of autoimmune diseases to enter the clinical stage. ICP-488 is...

miR Scientific and Leonie Hill Capital Announce Collaboration to Introduce Breakthrough Urine Liquid Biopsy Prostate Cancer Test in Singapore

High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, sophisticated healthcare access and distribution, announced today the signing of a...

Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages

NCCN Guidelines for Patients: Colorectal Cancer Screening now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer. PLYMOUTH MEETING, Pa.March 28, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Patients®: Colorectal Cancer Screening....

Innovent and Lilly Expand Strategic Partnership in Oncology

SAN FRANCISCO and INDIANAPOLIS and SUZHOU, China, March 28, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company ("Lilly", NYSE: LLY) today announced that in light of both parties' shared commitment to...

Ascletis Announces the Latest Results of the Preclinical Studies of Two Novel Anti-Cancer Drug Candidates, ASC61 and ASC60, to be presented at AACR Annual Meeting 2022

HANGZHOU, China and SHAOXING, China, March 27, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that the latest preclinical research results of the company's two novel anti-cancer drug candidates, ASC61, an oral PD-L1 inhibitor and ASC60, an oral fatty acid synthase (FASN)  inhibitor have been selected for presentations at the American Association for Cancer Research (AACR) Annual Meeting...

Kintor Pharma Announces 2021 Business Progress and Annual Results

SUZHOU, China, March 26, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended December 31, 2021. 2021 Annual Results Highlights Overview During the reporting period, Kintor Pharma achieved the zero breakthrough of revenue of RMB34.23...

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

SHANGHAI, March 25, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG (generic name: serplulimab injection) has been approved by the National Medical Products Administration (NMPA) for the treatment of adult patients with advanced unresectable or metastatic MSI-H (Microsatellite Instability-High) solid tumors that have failed to respond to previous standard treatments,...

Abcam the most awarded company at 2022 industry awards

CAMBRIDGE, England, March 25, 2022 /PRNewswire/ -- Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia...

EYE CARE TV of coocaa TV– Save Your Eyes

JAKARTA, Indonesia, March 25, 2022 /PRNewswire/ -- Recently, coocaa has launched EYE CARE TV S6G Pro Max which focusing on protecting people' eyes from screen flicker. People always neglect the harms of screen flicker for it cannot be felt easily. Actually, screen flicker is harmful and usual among our life. coocaa will tell you harms of flicker and the...